日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

How Transformative Are ROS Responsive Hydrogel Nanoformulations to Treat Refractory Infected Wounds

ROS响应型水凝胶纳米制剂在治疗难治性感染伤口方面具有怎样的变革性作用?

Liu, Zongjunlin; Xiang, Hongqiong; Xian, Ke; Cai, Lina; Yin, Dui; Zhong, Jianqiao

Enhancing Oncolytic Virus Therapy with Nanomedicine: A Review of Progress, Challenges, and Future Directions in a New Frontier of Cancer Treatment

利用纳米医学增强溶瘤病毒疗法:癌症治疗新前沿的进展、挑战和未来方向综述

Qiu, Jin; Liao, YongMei; Kan, Daohong; Liao, Li; Yang, Kaiwen; Hu, Xiaoran; Wang, Zhongming; Yu, Hongru; Xie, Fang; Liu, Zongjunlin

Tumor-microenvironment triggered Mn-Gd based nanosystem for breast carcinoma suppression via synergistic radiotherapy and glutathione-depleting along with glucose oxidase combination enhanced Ros storm

肿瘤微环境触发的基于Mn-Gd的纳米系统通过协同放射疗法和谷胱甘肽耗竭以及葡萄糖氧化酶的组合增强ROS风暴,从而抑制乳腺癌。

Su, Yonghui; Guo, Dongqun; Liang, Yinghao; Meiheriban, Tuerdimaimaiti; Chen, Siyu; Tang, Qian; Chen, Xiqian; Huang, Yan; Zhong, Jianqiao; Liu, Zongjunlin

Differential plasma proteome analysis reveals key proteins associated with insulin resistance in acne vulgaris patients

差异血浆蛋白质组分析揭示了寻常痤疮患者胰岛素抵抗相关的关键蛋白质

Rao, Yu; Lei, Zheng; Chen, Siyu; Zhu, Xiaoping; Jiang, Zongzhe; Xu, Yang; Xiong, Xia; Liao, Yongmei; Chen, Xiqian; Tang, Qian; Liu, Zongjunlin; Li, Changqiang

Synergistic strategies in photodynamic combination therapy for cancer: mechanisms, nanotechnology, and clinical translation

癌症光动力联合疗法中的协同策略:机制、纳米技术和临床转化

Kan, Daohong; Ding, Rong; Yang, Huchuan; Jia, Yuming; Lei, Kaijian; Wang, Zhongming; Zhang, Wei; Yang, Chaokun; Liu, Zongjunlin; Xie, Fang

New-generation photosensitizer-anchored gold nanorods for a single near-infrared light-triggered targeted photodynamic-photothermal therapy

用于单次近红外光触发靶向光动力-光热疗法的新一代光敏剂锚定金纳米棒

Liu, Zongjunlin; Xie, Fang; Xie, Jun; Chen, Jianhao; Li, Yang; Lin, Qin; Luo, Fanghong; Yan, Jianghua

N2E4, a Monoclonal Antibody Targeting Neuropilin-2, Inhibits Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma via Suppressing FAK/Erk/HIF-1α Signaling

N2E4 是一种针对神经纤毛蛋白-2 的单克隆抗体,可通过抑制 FAK/Erk/HIF-1α 信号传导抑制胰腺导管腺癌的肿瘤生长和转移

Li Wang, Lanlan Wang, Shengyu Wang, Zonglang Zhou, Zongjunlin Liu, Peilan Xu, Xian Luo, Ting Wu, Fanghong Luo, Jianghua Yan